PRO-DEX, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued
PRO-DEX, INC. (PDEX) had Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued of $4.00 thousand as of 2025-09-30, per its 10-Q filed 2025-10-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued · last filed 2025-10-30
- 2025-09-30: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $4.00K.
- 2025-03-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $60.00K.
- 2024-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $54.00K.
- 2024-09-30: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $6.00K.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued |
|---|---|
| 2025-09-30 | $4.00K 10-Q · filed 2025-10-30 |
| 2025-03-31 | $60.00K 10-Q · filed 2025-05-01 |
| 2024-12-31 | $54.00K 10-Q · filed 2025-01-30 |
| 2024-09-30 | $6.00K 10-Q · filed 2025-10-30 |
| 2024-03-31 | $69.00K 10-Q · filed 2025-05-01 |
| 2023-12-31 | $61.00K 10-Q · filed 2025-01-30 |
| 2023-09-30 | $7.00K 10-Q · filed 2024-10-31 |
| 2015-03-31 | $385.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $385.00K 10-Q · filed 2015-02-10 |
| 2014-09-30 | $366.00K 10-Q · filed 2014-11-13 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-13 |
| 2012-12-31 | $0.00 10-Q · filed 2013-02-13 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 |
| 2012-06-30 | $0.00 10-Q · filed 2013-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |